Bashir M Mohamed
Overview
Explore the profile of Bashir M Mohamed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Cooper S, Mohamed B, Elliott L, Mitchell Davies A, Feighery C, Kelly J, et al.
Methods Mol Biol
. 2015 Oct;
1326:67-77.
PMID: 26498614
The IN Cell Analyzer 1000 possesses several distinguishing features that make it a valuable tool in research today. This fully automated high content screening (HCS) system introduced quantitative fluorescent microscopy...
12.
Staedler D, Passemard S, Magouroux T, Rogov A, Maguire C, Mohamed B, et al.
Nanomedicine
. 2015 Feb;
11(4):815-24.
PMID: 25652898
From The Clinical Editor: Bismuth Ferrite nanoparticles (BFO-NP) have been recently successfully introduced as photodynamic tools and imaging probes. However, how these nanoparticles interact with various cells at the cellular...
13.
Rakovich T, Mahfoud O, Mohamed B, Prina-Mello A, Crosbie-Staunton K, Van Den Broeck T, et al.
ACS Nano
. 2014 May;
8(6):5682-95.
PMID: 24873349
Despite the widespread availability of immunohistochemical and other methodologies for screening and early detection of lung and breast cancer biomarkers, diagnosis of the early stage of cancers can be difficult...
14.
Saadeh F, Norris L, OToole S, Mohamed B, Langhe R, OLeary J, et al.
Thromb Res
. 2013 Oct;
132(5):627-34.
PMID: 24094893
Introduction: Ovarian cancer is known to display a particular association with venous thromboembolism (VTE) with reports up to 42% of patients developing thromboembolic complications. Tissue Factor (TF) and its inhibitor...
15.
Laios A, Mohamed B, Kelly L, Flavin R, Finn S, McEvoy L, et al.
Int J Mol Sci
. 2013 Jan;
14(1):2085-103.
PMID: 23340649
Platinum resistance is a major cause of treatment failure in ovarian cancer. We previously identified matrix metalloproteinase 9 (MMP-9) as a potential therapeutic target of chemoresistant disease. A2780cis (cisplatin-resistant) and...
16.
Mohamed B, Verma N, Davies A, McGowan A, Crosbie-Staunton K, Prina-Mello A, et al.
Nanomedicine (Lond)
. 2012 May;
7(8):1181-95.
PMID: 22625207
Aim: Rapidly expanding manufacture and use of nanomaterials emphasize the requirements for thorough assessment of health outcomes associated with novel applications. Post-translational protein modifications catalyzed by Ca(2+)-dependent peptidylargininedeiminases have been...
17.
Shvedova A, Kapralov A, Feng W, Kisin E, Murray A, Mercer R, et al.
PLoS One
. 2012 Apr;
7(3):e30923.
PMID: 22479306
Advancement of biomedical applications of carbonaceous nanomaterials is hampered by their biopersistence and pro-inflammatory action in vivo. Here, we used myeloperoxidase knockout B6.129X1-MPO (MPO k/o) mice and showed that oxidation...
18.
Mohamed B, Feighery C, Coates C, OShea U, Delaney D, OBriain S, et al.
Dig Dis Sci
. 2007 May;
53(1):52-61.
PMID: 17487584
Some patients with undiagnosed celiac disease have minor mucosal lesions that may not be apparent during routine histological analysis. Twenty-five such patients of our institution were discharged to their primary-care...
19.
Mohamed B, Feighery C, Kelly J, Coates C, OShea U, Barnes L, et al.
Dig Dis Sci
. 2006 Sep;
51(10):1862-8.
PMID: 16964549
Gluten-sensitive enteropathy is characterized by small intestinal damage. The pathogenic mechanisms involved are not precisely understood. There is recent interest in the possibility that matrix metalloproteinases might play a pathogenic...